Source: Beximco Pharmaceuticals Ltd. (BXPHARMA) | FY 2016-17 | Page 36

# Statement of Cash Flows

**Reporting Period:** For the Year ended June 30, 2017  
**Reporting Currency & Multiplier:** BDT (Amount in Taka) | **Scale Multiplier:** 1.0

### Statement of Cash Flows

| Particulars | July 2016 - June 2017 (12 Months) | January 2015 - June 2016 (18 Months) |
| --- | --- | --- |
| Cash Flows from Operating Activities : |  |  |
| Receipts from Customers and Others | 15,028,477,642 | 19,756,621,890 |
| Payments to Suppliers and Employees | (11,480,328,595) | (15,204,763,705) |
| Cash Generated from Operations | 3,548,149,047 | 4,551,858,185 |
| Interest Paid | (557,003,162) | (1,030,182,401) |
| Interest Received | 161,110,825 | 404,847,333 |
| Income Tax Paid | (518,291,724) | (757,245,805) |
| Net Cash Generated from Operating Activities | 2,633,964,986 | 3,169,277,312 |
| Cash Flows from Investing Activities : |  |  |
| Acquisition of Property, Plant and Equipment | (3,016,391,390) | (2,975,250,144) |
| Intangible Assets | (108,998,404) | (165,351,713) |
| Disposal of Property, Plant and Equipment | 22,059,127 | 9,583,953 |
| Dividend Received | 1,427,955 | 1,427,955 |
| Decrease in Short Term Investment | 552,460,907 | 1,035,989,018 |
| Net Cash Used in Investing Activities | (2,549,441,805) | (2,093,600,931) |
| Cash Flows from Financing Activities : |  |  |
| Net Increase/(Decrease) in Long Term Borrowings | 32,424,297 | 55,519,429 |
| Net Increase/(Decrease) in Short Term Borrowings | 130,113,725 | (378,148,721) |
| Dividend Paid | (193,154,407) | (754,165,099) |
| Net Cash Generated from Financing Activities | (30,616,385) | (1,076,794,391) |
| Increase/(Decrease) in Cash and Cash Equivalents | 53,906,796 | (1,118,010) |
| Cash and Cash Equivalents at Beginning of Period | 221,121,229 | 222,239,239 |
| Cash and Cash Equivalents at End of Period | 275,028,025 | 221,121,229 |
| Net Operating Cash Flow Per Share | 6.49 | 8.21 |
| Number of Shares used to compute Net Operating Cash Flow Per Share | 405,556,445 | 386,244,234 |